Sclerotherapy of varicose veins in patients with documented thrombophilia: A prospective controlled randomized study of 105 cases

Phlebology

Volumn 24, Issue 4, 2009, Pages 176-182

  Hamel Desnos, C M ^a   Gillet, J L ^b   Desnos, P R ^c   Allaert, F A ^d  

^a Saint Martin Private Hospital   (France)

^b Vascular Medicine Physician   (France)

^c Vascular Medicine   (France)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Factor V Leiden mutation; Foam sclerotherapy; Prophylaxis; Thrombosis; Varicose veins

Indexed keywords

AETOXISCLEROL; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; NADROPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; POLIDOCANOL; PROTHROMBIN; UNCLASSIFIED DRUG; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ECCHYMOSIS; FEMALE; FOAM; GENE MUTATION; HUMAN; INTRAVASCULAR ULTRASOUND; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLEROTHERAPY; SINGLE DRUG DOSE; SKIN INFLAMMATION; SUPERFICIAL THROMBOPHLEBITIS; SYNCOPE; THROMBOPHILIA; THROMBOSIS PREVENTION; VARICOSIS;

ADULT; AGED; AGED, 80 AND OVER; FACTOR V; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; THROMBOPHILIA; THROMBOSIS; VARICOSE VEINS; WARFARIN;

EID: 67749124541     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2009.008081     Document Type: Article

References (20)

1. Hanss M. Thrombophilie: indications du bilan d'hémostase en 2004 et perspectives d'avenir. Phlébologie 2004;57:403-407
2. Nicolaides AN, Breddin HK, Carpentier P, et al. Thrombophilia and venous thromboembolism. International Consensus Statement. Guidelines According to Scientific Evidence. Int Angiol 2005;24:1-26
3. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-1231
4. Franchini M, Veneri D, Salvagno GL, Manzato F, Lippi G. Inherited thrombophilia. Crit Rev Clin Lab Sci 2006; 43:249-290
5. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter. Registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005;31:123-128
6. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007;94:925-936 (Pubitemid 47236534)
7. Hamel-Desnos C, Ouvry P, Desnos P, Escalard JM, Allaert FA. Sclérothérapie et thrombophilie: démarche pour un consensus dans la sclérothérapie chez les thrombophiles. Phlébologie 2003;56:165-169
8. Hamel-Desnos C, Desnos P, Guias B. Sclérothérapie mousse et thrombophilie. Phlébologie 2005;58:327-337
9. Breu FX, Guggenbichler S, Wollmann J-C. 2nd European Consensus Meeting on Foam Sclerotherapy 2006 Tegernsee, Germany. VASA 2008;37(S/71):3-29
10. Kundu S, Lurie F, Millward SF, et al. Recommended reporting standards for endovenous ablation for the treatment of venous insufficiency: joint statement of the American Venous Forum and the Society of Interventional Radiology. J Vasc Interv Radiol 2007;18:1073-1080 (Pubitemid 47332237)
11. Bern MM, Lokich JJ. Very low doses of warfarin can prevent thrombosis in central venous catheters - a randomized prospective trial. Ann Intern Med 1990; 112:423-428
12. Poller L, McKernan A, Thomson JM, Elstein M, Hirsch PJ, Jones JB. Fixed mini dose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. Br Med J (Clin Res) 1987;295:1309-1312 (Pubitemid 18003544)
13. Tessari L. Nouvelle technique d'obtention de la scléromousse. Phlébologie 2000;53:129
14. Hamel-Desnos C, Ouvry P, Benigni J-P, et al. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2-year follow-up. 'The 3/1 Study'. Eur J Vasc Endovasc Surg 2007;34:723-729
15. Goldman MP, Bergan JJ, Guex JJ. Sclerotherapy Treatment of Varicose and Telangiectatic Leg Veins. 4th edn. Philadelphia, USA: Mosby Elsevier, 2007:220
16. Gachet G, Spini L. Sclérothérapie des varices sous anticoagulants. Phlébologie 2002;55:41-44
17. Conard J, Horellou MH, Elalamy I, Samama MM. Thromboses veineuses après sclérothérapie. Enquête clinico-biologique à propos de 42 observations. J Mal Vasc 1999;24(suppl. A):97
18. Ikeda M, Kawasaki T, Kambayashi J, et al. Sclerotherapy for varicose veins of the lower legs in patients with dysplasminogenemia. Surg Today 1997;27:714-718 (Pubitemid 27340427)
19. Hamel-Desnos C, Guias B, Quehe P, et al. Foam sclerotherapy of saphenous veins with or without compression stockings. Biological consequences on circulating blood. Controlled randomized study. European Venous Forum 2008 abstracts. In: Report on the Ninth Meeting of the European Venous Forum: Barcelona, Spain, 26-28 June 2008. Phlebology 2008;23:230-248
20. Myers KA. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 2008;36: 602-605